Form 4/A for RLAY Relay Therapeutics, Inc.
Accepted 2023-06-01 00:00:00 ET · period of report 2023-04-28 · accession 0001209191-23-033416 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-06-01 | 2023-04-28 | RLAY | Bergstrom Donald A | Pres, R, D | S - Sale | $11.16 | -2,850 | 241.2K | -1% | -$31.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-28 | S | D | 2,850 | $11.16 | 241,234 | D | — | — | (F1) This amendment is being filed to correct the number of shares sold to cover the reporting person's income tax withholding obligations upon the vesting of 9,071 shares of restricted stock units ("RSUs") on April 27, 2023, which was inadvertently understated in the reporting person's original Form 4. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs. (F2) Due to the error described above, the reporting person's original Form 4 incorrectly reported that the number of shares held by the reporting person was 242,701, including 222,544 shares underlying RSUs. As reported in this amendment, the correct number of shares held by the reporting person is 241,234, including 217,532 shares underlying RSUs. |